Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-09-27

Clinical Trial Update: Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating fosmidomycin with clindamycin, with or without artesunate, for malaria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Clindamycin
  • Fosmidomycin (fosmidomycin)

Snippet

Sponsor: Jomaa Pharma GmbH | Conditions: Malaria | Phase 2 | Status: WITHDRAWN